Back to results

Factor h fragment for use as an anti-angiogenic agent

The invention relates to a complement factor H fragment for use in the therapy and/or prophylaxis of a disease involving neovascularization.
POC in vivo in a choroidal neovascularization model

Keywords: Dry AMD - neovascularization

Patent Application number: France (NP) - 30 Déc. 2015 - 15 63465

Inventors:

ABACHE Toufik,DINET Virginie,JORIEUX Sylvie

Reference:

BIO14280-T1

Anne COCHI
Business Development Manager

Phone

E-mail

Patent filling date: 30-12-2015

Rare disease: No

Second indication: No

You might also be interested in

RT00623

Industry Research (screening, tox.studies, bioreactor, ...) Uses:

Oncology Therapy Area:

Cell Lines Type of research tool:

Hrln (hrar alpha) cell line

HRLN were generated by transfection of cervical cancer HeLa cells with the […]

Read more

RT00626

Industry Research (screening, tox.studies, bioreactor, ...) Uses:

Oncology Therapy Area:

Cell Lines Type of research tool:

Ug5ln gal4-hmr cell line

UG5LN were generated by transfection of osteocarcinoma cancer U2OS cells with the […]

Read more

RT00625

Industry Research (screening, tox.studies, bioreactor, ...) Uses:

Oncology Therapy Area:

Cell Lines Type of research tool:

Ug5ln cell line

UG5LN were generated by transfection of osteocarcinoma cancer U20S cells with the […]

Read more

RT00624

Industry Research (screening, tox.studies, bioreactor, ...) Uses:

Oncology Therapy Area:

Cell Lines Type of research tool:

Ualh cell line

UALH were generated by transfection of osteocarcinoma cancer U2OS cells with the […]

Read more

RT00586

Industry Research (screening, tox.studies, bioreactor, ...) Uses:

Oncology Therapy Area:

Cell Lines Type of research tool:

Ualh har cell line

UALH were generated by transfection of osteocarcinoma cancer U2OS cells with the […]

Read more

RT00582

Industry Research (screening, tox.studies, bioreactor, ...) Uses:

Oncology Therapy Area:

Cell Lines Type of research tool:

Palm cell line

PALM were generated by co-transfection of cervical cancer PC3 cells with the […]

Read more

RT00583

Industry Research (screening, tox.studies, bioreactor, ...) Uses:

Oncology Therapy Area:

Cell Lines Type of research tool:

Meln (her alpha) cell line

MELN were generated by transfection of breasr cancer MCF-7 cells with the […]

Read more

RT00621

Industry Research (screening, tox.studies, bioreactor, ...) Uses:

Oncology Therapy Area:

Cell Lines Type of research tool:

Hg5ln gal4-rtr beta cell line

HG5LN were generated by transfection of cervical cancer HeLa cells with the […]

Read more

RT00620

Industry Research (screening, tox.studies, bioreactor, ...) Uses:

Oncology Therapy Area:

Cell Lines Type of research tool:

Heln hrar alpha cell line

HELN were generated by transfection of cervical cancer HeLa cells with the […]

Read more

RT00558

Industry Research (screening, tox.studies, bioreactor, ...) Uses:

Oncology Therapy Area:

Cell Lines Type of research tool:

Hg5ln gal4-hppar alpha cell line

HG5LN were generated by transfection of cervical cancer HeLa cells with the […]

Read more

RT00559

Industry Research (screening, tox.studies, bioreactor, ...) Uses:

Oncology Therapy Area:

Cell Lines Type of research tool:

Hg5ln gal4-hppar gamma cell line

HG5LN were generated by transfection of cervical cancer HeLa cells with the […]

Read more

RT00569

Industry Research (screening, tox.studies, bioreactor, ...) Uses:

Oncology Therapy Area:

Cell Lines Type of research tool:

Hg5ln gal4-hppar beta/delta cell line

HG5LN were generated by transfection of cervical cancer HeLa cells with the […]

Read more